Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fanizza

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Contraception|January 1, 1995
Climacteric symptoms and control of the cycle in women aged 35 years or older taking an oral contraceptive with 0.150 mg desogestrel and 0.020 mg ethinylestradiolG F Trossarelli, G Gennarelli, C Benedetto, et al.
Archives of Gynecology and Obstetrics|January 1, 1993
Effects of an oral contraceptive combination containing 0.150 mg desogestrel plus 0.020 mg ethinyl estradiol on healthy premenopausal womenD de Aloysio, M Mauloni, A Roncuzzi, et al.
Gastroenterology|December 1, 1987
Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissueA Francavilla, A Di Leo, L Polimeno, et al.
Gastroenterology|October 1, 1987
Effect of spironolactone and potassium canrenoate on cytosolic and nuclear androgen and estrogen receptors of rat liverA Francavilla, A Di Leo, P K Eagon, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2001
Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II studyM De Lena, V Lorusso, A Latorre, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Contraception|January 1, 1995
Climacteric symptoms and control of the cycle in women aged 35 years or older taking an oral contraceptive with 0.150 mg desogestrel and 0.020 mg ethinylestradiolG F Trossarelli, G Gennarelli, C Benedetto, et al.
Archives of Gynecology and Obstetrics|January 1, 1993
Effects of an oral contraceptive combination containing 0.150 mg desogestrel plus 0.020 mg ethinyl estradiol on healthy premenopausal womenD de Aloysio, M Mauloni, A Roncuzzi, et al.
Gastroenterology|December 1, 1987
Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissueA Francavilla, A Di Leo, L Polimeno, et al.
Gastroenterology|October 1, 1987
Effect of spironolactone and potassium canrenoate on cytosolic and nuclear androgen and estrogen receptors of rat liverA Francavilla, A Di Leo, P K Eagon, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2001
Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II studyM De Lena, V Lorusso, A Latorre, et al.
Pageof 3